PNC 27 10mg

Comprehensive Guide to PNC-27 10mg: Anti-Cancer Peptide Structure, p53-MDM2 Interaction Research Standards, and Analytical Purity

Welcome to Suzhou Lanhai Peptide, your trusted global source for advanced synthetic peptides, amino acid derivatives, and specialized laboratory storage solutions. In modern oncology research, apoptotic pathway studies, and advanced pharmaceutical synthesis, investigating targeted anti-cancer peptide constructs requires absolute precision, verifiable purity, and strict compliance with research standards. When exploring p53-MDM2 binding inhibition, transmembrane pore formation, and selective tumor necrosis mechanisms, utilizing high-purity PNC-27 10mg is vital for achieving reproducible scientific outcomes.

This comprehensive guide explores the structural sequence, biochemical properties, analytical verification standards, and proper laboratory storage protocols for PNC-27 10mg. By examining real-world industry benchmarks and analytical chemistry standards, we outline why optimized sourcing and handling are fundamental to advanced oncology research.

1. Understanding PNC-27: Structure, Mechanism, and Research Scope

PNC-27 is a synthetic 22-amino acid chimeric peptide constructed by fusing a p53-derived peptide sequence (amino acids 12-26) with a trans-activating cell-penetrating peptide (plectin-1 binding domain). It is structured as PPWMKAAAVEHLAKKGKAEIHH-NH2, designed specifically to target cancer cell membranes.

The Mechanism of Action in Biomedical Research

In contemporary biochemical and pharmacological investigations, PNC-27 is examined for several key cellular pathways:

• Selective Tumor Necrosis: Research indicates that PNC-27 binds to HDM-2 (human double minute 2) proteins expressed on the membranes of various cancer cells, inducing transmembrane pore formation and leading to rapid, non-apoptotic necrotic cell death (lytic destruction) specifically in tumor cells while sparing normal, non-malignant cells.

• p53 Pathway Interaction: By mimicking specific p53-MDM2 interaction domains, investigators evaluate its influence on intracellular stress signaling, apoptotic activation, and cell cycle arrest in vitro.

• Oncological Model Studies: In vitro and animal model research focuses on its efficacy across diverse human cancer cell lines, investigating its stability in serum-rich environments and its potential as a targeted membrane-active oncology agent.

2. Analytical Verification and High-Purity Synthesis Standards

For institutional buyers, academic researchers, and biotechnology procurement managers, batch verification is paramount. Chimeric peptides containing hydrophobic domains and positive charges require rigorous solid-phase peptide synthesis (SPPS) and HPLC purification to prevent premature truncation or structural aggregation.

High-Performance Liquid Chromatography (HPLC)

Every batch of PNC-27 10mg distributed by Suzhou Lanhai Peptide undergoes rigorous verification via HPLC to guarantee purity levels exceeding 98% to 99%+, ensuring minimal synthetic impurities or truncated sequence fragments.

Mass Spectrometry (MS) Validation

Mass spectrometry confirms the exact molecular weight and amino acid sequence fidelity, ensuring that the synthesized 22-amino acid chimeric peptide matches theoretical molecular profiles precisely.

Technical Specification Comparison

Specification Parameter	Standard Research Grade	Premium Analytical Grade
Sequence Identity	PPWMKAAAVEHLAKKGKAEIHH-NH2	PPWMKAAAVEHLAKKGKAEIHH-NH2
Purity (HPLC)	$\ge 98.0\%$	$\ge 99.2\%$
Mass Spectrometry (MS)	Verified Molecular Weight	Verified Molecular Weight
Formulation	10mg Lyophilized Powder	10mg Lyophilized Powder
Storage Conditions	$-20^\circ C$ desiccated	$-20^\circ C$ desiccated

3. Laboratory Handling, Reconstitution, and Storage Protocols

Synthetic chimeric peptides like PNC-27 are supplied as stabilized, vacuum-freeze-dried (lyophilized) powders to maximize shelf-life stability. Proper laboratory handling is essential to preserve peptide integrity upon reconstitution.

Reconstitution Best Practices

• Solvent Selection: Reconstitute lyophilized PNC-27 10mg using sterile water for injection or analytical buffer solutions in a clean laminar flow hood.

• Avoiding Shear Stress: Introduce solvents gently down the inside wall of the vial rather than forcefully spraying liquid directly onto the lyophilized cake to prevent peptide bond shearing or hydrophobic aggregation.

Cold-Chain Storage Guidelines

• Dry Powder Storage: Store sealed vials of lyophilized PNC-27 at $-20^\circ C$ desiccated away from light and moisture.

• Reconstituted Storage: Once reconstituted, solutions should be kept between $2^\circ C$ and $8^\circ C$ and utilized within short-term experimental windows to prevent enzymatic degradation or precipitation.

4. Mandatory Research Disclaimer and Compliance

• For Laboratory and Research Use Only: All peptide products offered by Suzhou Lanhai Peptide, including PNC-27 10mg, are strictly intended for in vitro laboratory research, analytical testing, and scientific study. They are not approved for human consumption, clinical trials on humans, veterinary use, or therapeutic self-administration.

5. Frequently Asked Questions (FAQs)

1. What is the structural composition of PNC-27?

PNC-27 is a synthetic 22-amino acid chimeric peptide combining a p53-derived tumor-suppressor domain with a membrane-penetrating peptide sequence, terminating in an amide group.

2. What purity level does Suzhou Lanhai Peptide guarantee for PNC-27 10mg?

Every batch of PNC-27 10mg is backed by analytical documentation confirming an HPLC purity rating of 98% to 99% or higher.

3. How should lyophilized PNC-27 10mg be stored prior to reconstitution?

Lyophilized powder vials should be stored in a sealed, dry container at $-20^\circ C$ to maintain structural stability and prevent thermal degradation.

4. Are Certificates of Analysis (COAs) provided with orders?

Yes. Every order includes or provides access to batch-specific HPLC and Mass Spectrometry reports to verify purity and molecular weight for institutional compliance.

5. Can PNC-27 be used in human clinical applications?

No. All products sold by Suzhou Lanhai Peptide are restricted strictly to laboratory research and development use only and are prohibited from human or clinical application.